Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KANK4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | PHOSPHO2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | ACVR2B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
mRNA | HERPUD1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | RXRG | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | DICER1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | SFPQ | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | AHCYL2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | PRLH | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | TRAK2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |